Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Tecfidera

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tecfidera was produced by Biogen Idec.

Biogen raises full year guidance after beating Q2 expectations

Biogen raises full year guidance after beating Q2 expectations

The increasing sales of Tecfidera dampen some concerns that the drug was already facing uncertainty after Biogen lost a key patent back in June, setting it up for generic competition. ... The raised forecast does not include any operational impact from

Biogen completes filing for highly-anticipated Alzheimer’s drug

Biogen completes filing for highly-anticipated Alzheimer’s drug branded multiple sclerosis treatment Tecfidera.

J&J aims for US approval of MS drug ponesimod

J&J aims for US approval of MS drug ponesimod A range of blockbuster therapies are already available for MS, including Biogen’s Tecfidera (dimethyl glutamate) and new injectables like Roche’s Ocrevus (ocrelizumab). ... There is also the looming threat of generic competition to Gilenya and

Biogen triumphs over Mylan’s Tecfidera patent challenge

Biogen triumphs over Mylan’s Tecfidera patent challenge The challenge from Mylan focused on Biogen’s ‘514 patent on Tecfidera (dimethyl fumarate) , which is due to expire in 2028. ... Circuit to remove this patent from blocking generic competition to Tecfidera," they added.

Biogen under fire over $88,000 Vumerity annual price

Biogen under fire over $88,000 Vumerity annual price Vumerity is Biogen’s answer to the patent pressures on Tecfidera, but there have been concerns that. ... patients who are stable on Tecfidera will be unwilling to to transfer to the newer drug.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics